Showing results (561-570 of 667) with videos related to

Sort By:
Pageof 67
Journal of Neural Transmission. Supplementum|August 13, 1998
Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam StudyA J Slooter, C M van Duijn, M L Bots, et al.
American Journal of Epidemiology|June 29, 2000
Education and the risk for Alzheimer's disease: sex makes a difference. EURODEM pooled analyses. EURODEM Incidence Research GroupL Letenneur, L J Launer, K Andersen, et al.
Infection Control and Hospital Epidemiology|September 1, 2000
Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The NetherlandsN van den Braak, A Ott, A van Belkum, et al.
Neurology|December 22, 1999
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research GroupK Andersen, L J Launer, M E Dewey, et al.
Cancer Medicine|March 16, 2021
Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockadeElizabeth I Buchbinder, Jason L Weirather, Michael Manos, et al.
Cell Reports. Medicine|December 9, 2020
Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1Asaf Poran, Julian Scherer, Meghan E Bushway, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab ± Ipilimumab in Gastric Cancer/Gastroesophageal Junction CancerMing Lei, Nathan O Siemers, Dimple Pandya, et al.
Scientific Reports|January 22, 2020
Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized ImmunotherapyNicholas L Truex, Rebecca L Holden, Bin-You Wang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 20, 2012
Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph nodeMichelle W Ma, Ratna C Medicherla, Meng Qian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2017
Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 StudyPatrick A Ott, Yung-Jue Bang, Dominique Berton-Rigaud, et al.
Pageof 67